Blueprint Medicines Corporation Net Income per Employee (BPMC), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Blueprint Medicines Corporation  (NASDAQ: BPMC)
 

Blueprint Medicines Net Income per Employee

BPMC's Quarterly Results, Trends, Rankings, Statistics
Blueprint Medicines Corporation recorded a cumulative net loss of $-156 million during 12 month ending in the first quarter 2025.
The Healthcare sector has seen employees of 126 other companies achieving higher income per employee. While Blueprint Medicines's total ranking has deteriorated compared to the previous quarter from 1970 to 3132.


What is Income per Employee Ratio?






BPMC Net Income per Employee (Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
Y / Y Net Income Change -99.44 % - - - -
Net Income per Employee (TTM) $ -267,576 -115,273 -220,021 -353,074 -495,340
BPMC's Total Ranking # 3132 # 1970 # 2319 # 2445 # 2219
Seq. Net Income Change - - - - -


BPMC Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 127
Healthcare Sector # 380
Overall Market # 3132

Net Income per Employee Statistics
High Average Low
$ 584,455 $ -487,861 $ -1,232,916
(Jun 30 2021)   (Sep 30 2022)







Companies with similar Income per Employee for 12 month ending Mar 31 2025, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2025Number of Employees Mar 31 2025


Date modified: 2026-08-29T17:30:20+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.